Emergency Contraception Market Report 2026

Emergency Contraception Market Overview

• Emergency Contraception market size has reached to $1.55 billion in 2025 • Expected to grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Growing Rates Of Unprotected Intercourse Driving The Market Growth Due To Higher Prevalence Of Unprotected Sexual Encounters • Market Trend: Innovation Expanding Choice And Convenience In Reproductive Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Emergency Contraception Market?

Emergency contraception is a method used to prevent pregnancy after unprotected sexual intercourse or contraceptive failure. It typically involves high-dose hormonal pills or the insertion of a copper intrauterine device. Its effectiveness is highest when taken as soon as possible after the event, ideally within 72 hours. The main product types of emergency contraception include levonorgestrel, ulipristal acetate, mifepristone, and other product types. Levonorgestrel refers to a hormonal formulation used to prevent pregnancy after unprotected intercourse or contraceptive failure. The dosage forms include tablets, injections, and other dosage forms given to age groups that include adolescents and adults. The distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels, and they are utilized by hospitals, clinics, homecare, and other end users.

What Is The Emergency Contraception Market Growth Forecast?

The emergency contraception market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing adoption of online pharmacy platforms, growing demand for homecare delivery services, expansion of age-specific awareness programs, rising preference for non-hormonal and herbal alternatives, introduction of high-dose and multi-formulation products. Major trends in the forecast period include increasing availability of over-the-counter emergency contraceptives, rising adoption of online pharmacies and home delivery services, growing focus on adolescent and adult awareness programs, expansion of high-dose and multi-formulation options, rising integration of copper intrauterine devices and non-hormonal methods.

Global Emergency Contraception Market Segmentation

1) By Product Type: Levonorgestrel, Ulipristal Acetate, Mifepristone, Other Product Types 2) By Dosage Form: Tablets, Injections, Other Dosage Forms 3) By Age Group: Adolescents, Adults 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels 5) By End-User: Hospitals, Clinics, Homecare, Other End Users Subsegments: 1) By Levonorgestrel: Single Dose Tablets, Two Dose Tablets, Over The Counter Formulations, Prescription Based Formulations 2) By Ulipristal Acetate: Single Dose Tablets, Prescription Based Tablets, High Dose Formulations, Low Dose Formulations 3) By Mifepristone: Low Dose Emergency Use, Combination Regimen Formulations, Prescription Based Tablets, Clinical Setting Formulations 4) By Other Product Types: Copper Intrauterine Devices, Combined Hormonal Regimens, Non Hormonal Methods, Herbal Based Formulations

What Is The Driver Of The Emergency Contraception Market?

The growing rates of unprotected intercourse is expected to propel the growth of the emergency contraception market going forward. Unprotected intercourse refers to sexual activity carried out without using any form of barrier contraception, such as condoms, or other reliable birth control methods, leaving participants at risk of unintended pregnancy and sexually transmitted infections. Unprotected intercourse is rising due to decreasing condom use and inconsistent adoption of other contraceptive methods among sexually active individuals, especially young adults and adolescents, which increases the likelihood of unprotected sexual encounters. Emergency contraception provides an essential safety option after unprotected intercourse by preventing unintended pregnancies, thereby directly addressing the consequences of missed or no contraception and reducing the immediate risk associated with unprotected sexual activity. For instance, according to the 2023 National Youth Risk Behavior Survey by the Centers for Disease Control and Prevention, a US-based government agency, in a 2023 survey of U.S. high school students, 32% reported having had sexual intercourse at least once, and 48% stated that they did not use a condom during their most recent sexual encounter. Therefore, growing rates of unprotected intercourse is driving the growth of the emergency contraception industry.

Key Players In The Global Emergency Contraception Market

Major companies operating in the emergency contraception market are Pfizer Inc.; Bayer Aktiengesellschaft, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Limited, Amneal Pharmaceuticals Inc., Lupin Limited, Gedeon Richter Plc, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Mankind Pharma Limited, Piramal Pharma Limited, CooperSurgical Inc., HLL Lifecare Limited, Zhejiang Xianju Pharmaceutical Co. Ltd., AdvaCare Pharma, Afaxys Inc., Syzygy Healthcare Solutions, Foundation Consumer Healthcare, Shanghai Dahua Pharmaceutical Co. Ltd.

Global Emergency Contraception Market Trends and Insights

Major companies operating in the emergency contraception market are focusing on developing innovative products such as, over the counter emergency contraceptives to increase accessibility and provide rapid, effective pregnancy prevention. Over-the-counter emergency contraceptives are oral pills containing hormones such as levonorgestrel that can be purchased without a prescription and help prevent pregnancy by delaying ovulation or fertilization when taken shortly after unprotected sex. For instance, in August 2024, Verséa Health Inc., a US-based healthcare company specializing in diagnostics and consumer health solutions, launched empowered choice, a U.S. Food and Drug Administration–approved over‑the‑counter emergency contraceptive aimed at expanding accessible options in mainstream retail and online channels. The launch included nationwide distribution partnerships with major pharmacies and e-commerce platforms, combined with a comprehensive educational campaign to raise awareness about emergency contraception options, proper usage, and timing for optimal effectiveness. The initiative sought to reach a wider audience, reduce stigma around emergency contraception, and ensure that individuals could obtain the product quickly and discreetly. The product features a simple oral levonorgestrel formulation that ensures effective emergency pregnancy prevention, can be used without a prescription, and provides individuals with increased autonomy and flexibility in reproductive health decision-making.

What Are Latest Mergers And Acquisitions In The Emergency Contraception Market?

In March 2023, Curae Pharma360 Inc., a US-based pharmaceutical company that specializes in providing over-the-counter (OTC) emergency contraceptives, partnered with Direct Relief to provide over-the-counter emergency contraception to underserved women. With this partnership, Curae Pharma360 Inc. and Direct Relief aim to improve equitable access to essential medicines, deliver timely reproductive healthcare solutions, and support community health initiatives targeting women in need. Direct Relief is a US-based nonprofit organization that provides medical assistance and disaster relief to improve health outcomes.

Regional Insights

North America was the largest region in the emergency contraception market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Emergency Contraception Market?

The emergency contraception market consists of sales of combined hormonal emergency contraceptive pills, copper intrauterine devices (IUDs), over-the-counter emergency contraceptive products, and emergency contraceptive pill kits. Values in this market are “factory gate” values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services such as regulatory compliance support, packaging, labeling, and pharmacovigilance services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Emergency Contraception Market Report 2026?

The emergency contraception market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the emergency contraception industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.